Federal Register / Vol. 74, No. 76 / Wednesday, April 22, 2009 / Notices 18389 

Institute on Aging, Gateway Building 2C/212, 

7201 Wisconsin Avenue, Bethesda, MD 

20892, 301–402–7703, 

parsadaniana@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Aging and 

Economics. 

Date: June 17, 2009. 

Time: 11 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

National Institutes of Health, Gateway 

Building, Room 2C/212, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Rebecca J. Ferrell, PhD, 

Scientific Review Officer, National Institute 

on Aging, Gateway Building 2C212, 7201 

Wisconsin Avenue, Bethesda, MD 20814, 

301–402–7703, ferrellrj@mail.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, 

Mitochondrial Antioxidants and Aging. 

Date: June 19, 2009. 

Time: 11 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

National Institutes of Health, Gateway 

Building, Room 2C/212, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Alexander Parsadanian, 

PhD, Scientific Review Officer, National 

Institute on Aging, Gateway Building 2C/212, 

7201 Wisconsin Avenue, Bethesda, MD 

20892, 301–402–7703, 

parsadaniana@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: April 16, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–9276 Filed 4–21–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Neurological 

Disorders and Stroke Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council. 

Date: May 28–29, 2009. 

Open: May 28, 2009, 10:30 a.m. to 4:45 

p.m. 

Agenda: Report by the Director, NINDS; 

Report by the Associate Director for 

Extramural Research; Other Administrative 

and Program Developments; and an 

Overview of the NINDS Intramural Program. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C Wing, 

Conference Room 10, Bethesda, MD 20892. 

Closed: May 28, 2009, 4:45 p.m. to 5:15 

p.m. 

Agenda: To review and evaluate the 

Division of Intramural Research Board of 

Scientific Counselors’ Reports. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C Wing, 

Conference Room 10, Bethesda, MD 20892. 

Closed: May 29, 2009, 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C Wing, 

Conference Room 10, Bethesda, MD 20892. 

Contact Person: Robert Finkelstein, Ph.D., 

Associate Director for Extramural Research, 

National Institute of Neurological, Disorders 

and Stroke, NIH, 6001 Executive Blvd., Suite 

3309, MSC 9531, Bethesda, MD 20892, (301) 

496–9248. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.ninds.nih.gov, where an agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: April 16, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–9225 Filed 4–21–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Advisory Neurological 

Disorders and Stroke Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Neurological Disorders and Stroke Council, 

Clinical Trials Subcommittee. 

Date: May 27–28, 2009. 

Closed: May 27, 2009, 6 p.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Open: May 28, 2009, 8 a.m. to 10 a.m. 

Agenda: To discuss clinical trials policy. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 10, Bethesda, MD 20892. 

Contact Person: Deborah G Hirtz, MD, 

Acting Director, Clinical Trials Cluster, 

National Institute of Neurological Disorders 

and Stroke, National Institute of Health, 6001 

Executive Blvd., Suite 2212, Bethesda, MD 

20892. (301) 496–5821. hirtz@ninds.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 


dwashington3 on PROD1PC60 with NOTICES